The Pediatric COVID-19 Registry in Kuwait: Methodology and Results of Pilot Phase

Sarah Qabazard1, Dalia Al-Abdulrazzaq2, Hessa Al-Kandari1,3

  • 1Department of Population Health, Dasman Diabetes Institute, Kuwait City, Kuwait.

Insights

Kuwait established a pediatric COVID-19 registry (PCR-Q8) to track severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) in children. The pilot phase showed most pediatric cases were mild, with fever being the most common symptom.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Public Health Surveillance

Background:

  • The COVID-19 pandemic necessitated rapid data collection on pediatric infections.
  • Establishing a dedicated registry was crucial for understanding disease patterns in children.
  • Kuwait aimed to create a robust system for tracking severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) in its pediatric population.

Purpose of the Study:

  • To describe the establishment and pilot phase results of the Pediatric COVID-19 Registry in Kuwait (PCR-Q8).
  • To analyze the mode of presentation, interventions, severity, and early outcomes of SARS-CoV-2 infection in children.
  • To showcase the infrastructure and development process of a national pediatric disease registry.

Main Methods:

  • The registry development followed best practices from "Registries for Evaluating Patient Outcomes: A User's Guide."
  • Leveraged experience from a prior pediatric diabetes registry and global COVID-19 registries.
  • Pilot phase included a convenience sample of 120 children, with data collected on demographics, symptoms, and clinical findings.

Main Results:

  • Most children (69.2%) presented with mild COVID-19 disease.
  • A majority (70.2%) had normal chest X-rays.
  • Fever (77%) was the most frequent presenting symptom in pediatric SARS-CoV-2 cases.

Conclusions:

  • The successful establishment of the PCR-Q8 registry provides a foundation for further pediatric SARS-CoV-2 research in Kuwait.
  • This initiative can serve as a model for developing other disease-specific registries for children.
  • Effective collaboration and adherence to international guidelines were key to the registry's rapid implementation.
Abstract